TQQQ vs XBI

ProShares UltraPro QQQ vs SPDR S&P Biotech ETF

Quick take
  • XBI has the lower expense ratio at 0.35% vs 0.82% for TQQQ.
  • TQQQ pays a higher dividend yield (0.46%).

Side-by-side metrics

MetricTQQQXBI
Expense ratio
Annual fee. Lower is better.
0.82%0.35%
Dividend yield
Trailing 12-month yield.
0.46%0.36%
AUM
Assets under management — bigger funds are typically more liquid.
$38.97B$10.73B
YTD return
38.48%33.79%
1-year return
3-year return
Annualized.
5-year return
Annualized.
10-year return
Annualized.
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
3.961.10
P/E ratio
39.14
Last price
$76.34$164.28
Inception
Issuer
ProSharesState Street

TQQQ top holdings

Top holdings · TQQQ
IQMMProShares GENIUS Money Market ETF17.16%
Sector breakdown · TQQQ
Real Estate0.1%
Consumer Cyclical12.3%
Basic Materials1.1%
Consumer Defensive7.7%
Technology53.8%
Communication Services15.8%
Financial Services0.2%
Utilities1.4%
Industrials2.8%
Energy0.6%
Healthcare4.2%

XBI top holdings

Top holdings · XBI
APGEApogee Therapeutics Inc1.49%
MRNAModerna Inc1.41%
TWSTTwist Bioscience Corp1.41%
ORKAOruka Therapeutics Inc1.38%
KYMRKymera Therapeutics Inc Ordinary Shares1.36%
VKTXViking Therapeutics Inc1.30%
PRAXPraxis Precision Medicines Inc Ordinary Shares1.29%
ERASErasca Inc1.27%
RVMDRevolution Medicines Inc Ordinary Shares1.20%
RYTMRhythm Pharmaceuticals Inc1.20%
Sector breakdown · XBI
Financial Services0.5%
Healthcare99.5%

About TQQQ

TQQQ (ProShares UltraPro QQQ) is 3x leveraged daily performance of the Nasdaq-100. Managed by ProShares, the fund carries $39.0B in assets under management, an expense ratio of 0.82%, a dividend yield of 0.46%. Its largest holding is ProShares GENIUS Money Market ETF (IQMM), which represents 17.2% of the portfolio. Real Estate is the fund's largest sector exposure at 0.1%.

About XBI

XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.